Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation

J Neural Transm (Vienna). 2005 Apr;112(4):491-8. doi: 10.1007/s00702-005-0277-5. Epub 2005 Feb 15.

Abstract

Previously we showed that repetitive inhibition of oxidative phosphorylation impairs synaptic transmission and induces overexpression of amyloid precursor protein mRNA (APP-mRNA) in the hippocampus (Hellweg et al., 2003). Here we show that APP-mRNA remains alike in murine frontal cortex and cerebellum on repetitive treatment with 3-nitropropionate. However, nerve growth factor and brain-derived neurotrophic factor decreased by 28 to 38% in frontal cortex. Taken together, the pattern of change resembles genetic models of Alzheimer's disease with less susceptibility for overexpression of amyloid mRNA in frontal cortex than in hippocampus and reduced neurotrophin levels in frontal cortex. Given the similarity of this pattern to the one observed in human Alzheimer's disease the present model in future may give further insight into the pathophysiology of sporadic Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology
  • Amyloid beta-Protein Precursor / genetics*
  • Animals
  • Brain / metabolism*
  • Brain Chemistry / physiology*
  • Brain-Derived Neurotrophic Factor / drug effects
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cerebellum / drug effects
  • Cerebellum / metabolism
  • Convulsants / pharmacology
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Energy Metabolism / physiology
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Genetic Predisposition to Disease / genetics
  • Hypoxia, Brain / metabolism
  • Hypoxia, Brain / physiopathology
  • Male
  • Mice
  • Nerve Growth Factor / drug effects
  • Nerve Growth Factor / metabolism
  • Nerve Growth Factors / metabolism*
  • Nitro Compounds
  • Oxidative Phosphorylation / drug effects
  • Propionates / pharmacology
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism*
  • Succinate Dehydrogenase / metabolism

Substances

  • Amyloid beta-Protein Precursor
  • Brain-Derived Neurotrophic Factor
  • Convulsants
  • Nerve Growth Factors
  • Nitro Compounds
  • Propionates
  • RNA, Messenger
  • Nerve Growth Factor
  • Succinate Dehydrogenase
  • 3-nitropropionic acid